Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition

L Lorenzetti, N Dinh, A van der Straten… - Journal of the …, 2023 - Wiley Online Library
Abstract Introduction Pre‐exposure prophylaxis (PrEP) is an important HIV prevention
option. Two randomized trials have provided efficacy evidence for long‐acting injectable …

Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature

FM Koechlin, VA Fonner, SL Dalglish, KR O'Reilly… - AIDS and Behavior, 2017 - Springer
Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative
people to prevent HIV infection. WHO released new guidelines in 2015 recommending PrEP …

Tenofovir-based preexposure prophylaxis for HIV infection among African women

JM Marrazzo, G Ramjee, BA Richardson… - … England Journal of …, 2015 - Mass Medical Soc
Background Reproductive-age women need effective interventions to prevent the
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

JM Baeten, D Donnell, P Ndase… - New England journal …, 2012 - Mass Medical Soc
Background Antiretroviral preexposure prophylaxis is a promising approach for preventing
human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations …

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

RM Grant, JR Lama, PL Anderson… - … England Journal of …, 2010 - Mass Medical Soc
Background Antiretroviral chemoprophylaxis before exposure is a promising approach for
the prevention of human immunodeficiency virus (HIV) acquisition. Methods We randomly …

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention

D Donnell, JM Baeten, NN Bumpus… - JAIDS Journal of …, 2014 - journals.lww.com
Background: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention
strategy for which adherence is a known determinant of efficacy. Blood concentrations of …

From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City

SA Golub, KE Gamarel, HJ Rendina… - AIDS patient care and …, 2013 - liebertpub.com
This study examined potential facilitators and barriers to pre-exposure prophylaxis (PrEP)
use and their association with PrEP acceptability and motivations for adherence among 184 …

Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women

L Goparaju, NC Praschan… - Journal of AIDS & …, 2017 - pmc.ncbi.nlm.nih.gov
Background Pre-Exposure Prophylaxis (PrEP) use has remained low among US women
while significantly increasing among men who have sex with men. Besides lack of …

Impact of the Centers for Disease Control's HIV preexposure prophylaxis guidelines for men who have sex with men in the United States

SM Jenness, SM Goodreau… - The Journal of …, 2016 - academic.oup.com
Background Preexposure prophylaxis (PrEP) is effective for preventing human
immunodeficiency virus (HIV) infection among men who have sex with men (MSM) within …

PrEP rollout in Africa: status and opportunity

EM Irungu, JM Baeten - Nature medicine, 2020 - nature.com
Following recommendations by the World Health Organization in 2015, and key clinical
trials, countries in sub-Saharan Africa, the region with the highest burden of human …